Ambalal Sarabhai Enterprises Stock Screener | Share Price & Fundamental Analysis
AMBALALSA
Pharmaceuticals
Screen Ambalal Sarabhai Enterprises share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹27.45
▼
-0.40 (-1.44%)
Market Cap
₹213.87 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
1.42
EPS (TTM)
₹0.64
Dividend Yield
-
Debt to Equity
0.35
52W High
₹53.24
52W Low
₹26.39
Operating Margin
1.00%
Profit Margin
-2.17%
Revenue (TTM)
₹46.00
EBITDA
₹2.00
Net Income
₹-1.00
Total Assets
₹270.00
Total Equity
₹140.00
Ambalal Sarabhai Enterprises Share Price History - Stock Screener Chart
Screen AMBALALSA historical share price movements with interactive charts. Analyze price trends and patterns.
Ambalal Sarabhai Enterprises Company Profile - Fundamental Screener
Screen Ambalal Sarabhai Enterprises company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for AMBALALSA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE432A01017
Ambalal Sarabhai Enterprises Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen AMBALALSA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 270 | 250 | 246 | 231 | 210 | 186 | 215 | 200 | 164 | 180 |
| Current Assets | 119 | 119 | 111 | 120 | 121 | 104 | 116 | 114 | 73 | 89 |
| Fixed Assets | 88 | 88 | 85 | 58 | 57 | 58 | 58 | 59 | 72 | 72 |
| Liabilities | ||||||||||
| Total Liabilities | 270 | 250 | 246 | 231 | 210 | 186 | 215 | 200 | 164 | 180 |
| Current Liabilities | 10 | 11 | 12 | 5 | 8 | 8 | 13 | 18 | 14 | 13 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 140 | 136 | 131 | 120 | 74 | 45 | 31 | 27 | 25 | 39 |
| Share Capital | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 |
| Reserves & Surplus | 63 | 60 | 54 | 43 | -3 | -32 | -46 | -50 | -52 | -38 |
Screen AMBALALSA income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 46 | 49 | 66 | 52 | 48 | 43 | 59 | 45 | 43 | 38 | 50 | 38 | 49 | 46 | 63 |
| Expenses | 44 | 39 | 67 | 47 | 42 | 40 | 50 | 41 | 39 | 40 | 41 | 34 | 46 | 43 | 53 |
| EBITDA | 2 | 10 | 0 | 5 | 5 | 3 | 9 | 4 | 4 | -3 | 9 | 5 | 3 | 3 | 10 |
| Operating Profit % | 1.00% | 4.00% | -3.00% | -2.00% | 6.00% | 1.00% | 9.00% | 6.00% | 3.00% | -11.00% | 8.00% | 4.00% | 2.00% | 2.00% | 2.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 8 | -2 | 3 | 3 | 1 | 8 | 2 | 2 | -5 | 7 | 4 | 2 | 2 | 9 |
| Tax | 1 | 0 | -2 | 1 | 1 | 1 | -1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 |
| Net Profit | -1 | 8 | 0 | 2 | 3 | 0 | 9 | 1 | 1 | -5 | 6 | 3 | 1 | 2 | 8 |
| EPS | -0.07 | 1.07 | -0.04 | 0.29 | 0.34 | 0.05 | 1.18 | 0.15 | 0.14 | -0.64 | 0.72 | 0.40 | 0.13 | 0.21 | 0.99 |
Ambalal Sarabhai Enterprises Cash Flow Screener - Liquidity Fundamentals
Screen AMBALALSA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -18 | 9 | 6 | 12 | -2 | -7 | 19 | -7 | 5 | -75 |
| Investing Activities | 13 | -5 | -17 | 5 | 10 | 17 | -9 | 18 | -3 | 80 |
| Financing Activities | -2 | -3 | 9 | -19 | -6 | -14 | -6 | -2 | -6 | -3 |
| Net Cash Flow | -6 | 1 | -2 | -3 | 2 | -4 | 4 | 8 | -4 | 2 |
Screen AMBALALSA shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 31.35% | 31.35% | 31.35% | 30.77% | 30.77% | 31.35% | 31.35% | 30.77% |
| FII Holding | 0.38% | 0.38% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.10% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.10% | 0.01% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 57.42% | 58.06% | 58.36% | 57.92% | 57.93% | 57.59% | 57.08% | 61.64% |
| Other Holding | 10.75% | 10.20% | 9.95% | 11.30% | 11.29% | 11.06% | 11.47% | 7.58% |
| Shareholder Count | 170,912 | 169,630 | 170,015 | 170,079 | 169,228 | 172,338 | 171,221 | 178,274 |
Ambalal Sarabhai Enterprises Dividend Screener - Share Yield Analysis
Screen AMBALALSA dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Ambalal Sarabhai Enterprises Index Membership - Market Screener Classification
Screen AMBALALSA by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Ambalal Sarabhai Enterprises Market Events Screener - Corporate Actions
Screen AMBALALSA market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 0.33% | ||
| Extraordinary General Meeting | NA | 24.58% | ||
| Annual General Meeting | NA | 36.67% | ||
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -3.59% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | -8.25% |
| 2025-07-31 | 2025-07-31 | Annual General Meeting | NA | -14.69% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 1.28% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | 0.14% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 5.94% |
| 2024-06-29 | 2024-06-29 | Annual General Meeting | NA | 2.31% |
Ambalal Sarabhai Enterprises Competitors Screener - Peer Comparison
Screen AMBALALSA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 418,660 | 39.94 | 54,729 | 9.71% | 10,980 | 42.57 |
| Divis Laboratories | 171,984 | 68.16 | 9,712 | 18.67% | 2,191 | 54.31 |
| Torrent Pharmaceuticals | 128,619 | 59.46 | 11,539 | 6.99% | 1,911 | 59.28 |
| Cipla | 122,544 | 22.28 | 28,410 | 7.12% | 5,291 | 51.13 |
| Dr Reddys Laboratories | 106,680 | 18.62 | 33,741 | 16.73% | 5,725 | 57.95 |
| Lupin | 97,097 | 22.26 | 22,910 | 13.74% | 3,306 | 65.19 |
| Zydus Life Science | 92,533 | 18.28 | 23,511 | 18.55% | 4,615 | 40.83 |
| Mankind Pharma | 89,655 | 49.87 | 12,744 | 20.90% | 2,007 | 42.47 |
| Aurobindo Pharma | 71,154 | 20.54 | 32,346 | 9.43% | 3,484 | 60.10 |
| Alkem Laboratories | 66,424 | 27.37 | 13,458 | 3.70% | 2,216 | 43.27 |
Ambalal Sarabhai Enterprises Company Announcements - News Screener
Screen AMBALALSA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-12 | Results For The Quarter And Half Year Ended 30.09.2025 | View |
| 2025-11-12 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 12.11.2025 | View |
| 2025-11-06 | Announcement Under Regulation 30 Of SEBI (LODR) | View |
| 2025-11-04 | Board Meeting Intimation for Approval Of Unaudited Financial Results Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended September 30 2025 Along With Limited Review Report Of Auditors Thereon. | View |
| 2025-10-27 | Announcement Under Regulation 30 Of SEBI (LODR) | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Announcement Under Regulation 30 Of SEBI (LODR) | View |
| 2025-09-29 | Closure of Trading Window | View |
| 2025-08-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-13 | Results - Financial Results For The Quarter Ended 30.06.2025 | View |
| 2025-08-13 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 13.08.2025 | View |
| 2025-08-04 | Board Meeting Intimation for Approval Of Financial Results For The Quarter Ended 30.06.2025 | View |
| 2025-08-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-07-31 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-07-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-07-09 | Letter Sent To Shareholder | View |
| 2025-07-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-07-05 | Reg. 34 (1) Annual Report. | View |
| 2025-06-24 | Closure of Trading Window | View |